NCT02593383

Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne

A Placebo Control, Multicenter, Randomized, Double Blind, Multi-formula Groups, and Parallel Phase Ⅰb+Ⅱa Study Evaluating the Safety and Efficacy of Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 245 (actual)
• Sponsor: Lee's Pharmaceutical Limited · Industry
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

evaluate the safety and efficacy of Compound Adapalene and Clindamycin Hydrochloride Gel in treatment of chinese patients with acne.

Conditions

• Acne

Interventions

Type	Name	Description
DRUG	Adapalene + Clindamycin Hydrochloride	0.1% Adapalene + 1% Clindamycin Hydrochloride
DRUG	Adapalene + Clindamycin Hydrochloride	0.1% Adapalene + 2% Clindamycin Hydrochloride
DRUG	Adapalene + Clindamycin Hydrochloride	0.05% Adapalene + 0.5% Clindamycin Hydrochloride
DRUG	Adapalene + Clindamycin Hydrochloride	0.05% Adapalene + 1% Clindamycin Hydrochloride
DRUG	Placebo

Timeline

• Start date: 2015-03-01
• Primary completion: 2017-07-31
• Completion: 2017-07-31
• First posted: 2015-11-02
• Last updated: 2019-09-24

Locations

1 site across 1 country: China